img

Global Parasitic Diseases Therapeutic Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Parasitic Diseases Therapeutic Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria.
Parasitic Diseases Therapeutic report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Parasitic Diseases Therapeutic market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Commercial and Household are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Parasitic Diseases Therapeutic industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Parasitic Diseases Therapeutic key companies include Bayer, F. Hoffmann-La Roche, GlaxoSmithKline, Pfizer and Sanaria, etc. Bayer, F. Hoffmann-La Roche, GlaxoSmithKline are top 3 players and held % share in total in 2022.
Parasitic Diseases Therapeutic can be divided into Peptides Medicine, Insect Repellent, Acaricide and Other, etc. Peptides Medicine is the mainstream product in the market, accounting for % share globally in 2022.
Parasitic Diseases Therapeutic is widely used in various fields, such as Commercial and Household, etc. Commercial provides greatest supports to the Parasitic Diseases Therapeutic industry development. In 2022, global % share of Parasitic Diseases Therapeutic went into Commercial filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Parasitic Diseases Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Pfizer
Sanaria
Segment by Type
Peptides Medicine
Insect Repellent
Acaricide
Other

Segment by Application


Commercial
Household
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Parasitic Diseases Therapeutic market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Parasitic Diseases Therapeutic introduction, etc. Parasitic Diseases Therapeutic Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Parasitic Diseases Therapeutic market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Parasitic Diseases Therapeutic
1.1 Parasitic Diseases Therapeutic Market Overview
1.1.1 Parasitic Diseases Therapeutic Product Scope
1.1.2 Parasitic Diseases Therapeutic Market Status and Outlook
1.2 Global Parasitic Diseases Therapeutic Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Parasitic Diseases Therapeutic Market Size by Region (2024-2034)
1.4 Global Parasitic Diseases Therapeutic Historic Market Size by Region (2024-2024)
1.5 Global Parasitic Diseases Therapeutic Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Parasitic Diseases Therapeutic Market Size (2024-2034)
1.6.1 North America Parasitic Diseases Therapeutic Market Size (2024-2034)
1.6.2 Europe Parasitic Diseases Therapeutic Market Size (2024-2034)
1.6.3 Asia-Pacific Parasitic Diseases Therapeutic Market Size (2024-2034)
1.6.4 Latin America Parasitic Diseases Therapeutic Market Size (2024-2034)
1.6.5 Middle East & Africa Parasitic Diseases Therapeutic Market Size (2024-2034)
2 Parasitic Diseases Therapeutic Market by Type
2.1 Introduction
2.1.1 Peptides Medicine
2.1.2 Insect Repellent
2.1.3 Acaricide
2.1.4 Other
2.2 Global Parasitic Diseases Therapeutic Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Parasitic Diseases Therapeutic Historic Market Size by Type (2024-2024)
2.2.2 Global Parasitic Diseases Therapeutic Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Parasitic Diseases Therapeutic Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Parasitic Diseases Therapeutic Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Parasitic Diseases Therapeutic Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Parasitic Diseases Therapeutic Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Parasitic Diseases Therapeutic Revenue Breakdown by Type (2024-2034)
3 Parasitic Diseases Therapeutic Market Overview by Application
3.1 Introduction
3.1.1 Commercial
3.1.2 Household
3.2 Global Parasitic Diseases Therapeutic Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Parasitic Diseases Therapeutic Historic Market Size by Application (2024-2024)
3.2.2 Global Parasitic Diseases Therapeutic Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Parasitic Diseases Therapeutic Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Parasitic Diseases Therapeutic Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Parasitic Diseases Therapeutic Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Parasitic Diseases Therapeutic Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Parasitic Diseases Therapeutic Revenue Breakdown by Application (2024-2034)
4 Parasitic Diseases Therapeutic Competition Analysis by Players
4.1 Global Parasitic Diseases Therapeutic Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parasitic Diseases Therapeutic as of 2022)
4.3 Date of Key Players Enter into Parasitic Diseases Therapeutic Market
4.4 Global Top Players Parasitic Diseases Therapeutic Headquarters and Area Served
4.5 Key Players Parasitic Diseases Therapeutic Product Solution and Service
4.6 Competitive Status
4.6.1 Parasitic Diseases Therapeutic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer
5.1.1 Bayer Profile
5.1.2 Bayer Main Business
5.1.3 Bayer Parasitic Diseases Therapeutic Products, Services and Solutions
5.1.4 Bayer Parasitic Diseases Therapeutic Revenue (US$ Million) & (2024-2024)
5.1.5 Bayer Recent Developments
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Profile
5.2.2 F. Hoffmann-La Roche Main Business
5.2.3 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Revenue (US$ Million) & (2024-2024)
5.2.5 F. Hoffmann-La Roche Recent Developments
5.3 GlaxoSmithKline
5.3.1 GlaxoSmithKline Profile
5.3.2 GlaxoSmithKline Main Business
5.3.3 GlaxoSmithKline Parasitic Diseases Therapeutic Products, Services and Solutions
5.3.4 GlaxoSmithKline Parasitic Diseases Therapeutic Revenue (US$ Million) & (2024-2024)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Parasitic Diseases Therapeutic Products, Services and Solutions
5.4.4 Pfizer Parasitic Diseases Therapeutic Revenue (US$ Million) & (2024-2024)
5.4.5 Pfizer Recent Developments
5.5 Sanaria
5.5.1 Sanaria Profile
5.5.2 Sanaria Main Business
5.5.3 Sanaria Parasitic Diseases Therapeutic Products, Services and Solutions
5.5.4 Sanaria Parasitic Diseases Therapeutic Revenue (US$ Million) & (2024-2024)
5.5.5 Sanaria Recent Developments
6 North America
6.1 North America Parasitic Diseases Therapeutic Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Parasitic Diseases Therapeutic Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Parasitic Diseases Therapeutic Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Parasitic Diseases Therapeutic Market Dynamics
11.1 Parasitic Diseases Therapeutic Industry Trends
11.2 Parasitic Diseases Therapeutic Market Drivers
11.3 Parasitic Diseases Therapeutic Market Challenges
11.4 Parasitic Diseases Therapeutic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Parasitic Diseases Therapeutic Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Parasitic Diseases Therapeutic Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Parasitic Diseases Therapeutic Market Size Share by Region (2024-2024)
Table 4. Global Parasitic Diseases Therapeutic Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Parasitic Diseases Therapeutic Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Parasitic Diseases Therapeutic Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Parasitic Diseases Therapeutic Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Parasitic Diseases Therapeutic Revenue Market Share by Type (2024-2024)
Table 9. Global Parasitic Diseases Therapeutic Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Parasitic Diseases Therapeutic Revenue Market Share by Type (2024-2034)
Table 11. North America Parasitic Diseases Therapeutic Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Parasitic Diseases Therapeutic Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Parasitic Diseases Therapeutic Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Parasitic Diseases Therapeutic Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Parasitic Diseases Therapeutic Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Parasitic Diseases Therapeutic Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Parasitic Diseases Therapeutic Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Parasitic Diseases Therapeutic Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Parasitic Diseases Therapeutic Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Parasitic Diseases Therapeutic Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Parasitic Diseases Therapeutic Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Parasitic Diseases Therapeutic Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Parasitic Diseases Therapeutic Revenue Market Share by Application (2024-2024)
Table 24. Global Parasitic Diseases Therapeutic Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Parasitic Diseases Therapeutic Revenue Market Share by Application (2024-2034)
Table 26. North America Parasitic Diseases Therapeutic Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Parasitic Diseases Therapeutic Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Parasitic Diseases Therapeutic Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Parasitic Diseases Therapeutic Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Parasitic Diseases Therapeutic Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Parasitic Diseases Therapeutic Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Parasitic Diseases Therapeutic Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Parasitic Diseases Therapeutic Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Parasitic Diseases Therapeutic Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Parasitic Diseases Therapeutic Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Parasitic Diseases Therapeutic Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Parasitic Diseases Therapeutic Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parasitic Diseases Therapeutic as of 2022)
Table 39. Date of Key Players Enter into Parasitic Diseases Therapeutic Market
Table 40. Global Parasitic Diseases Therapeutic Key Players Headquarters and Area Served
Table 41. Parasitic Diseases Therapeutic Product Solution and Service
Table 42. Global Parasitic Diseases Therapeutic Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bayer Basic Information List
Table 45. Bayer Description and Business Overview
Table 46. Bayer Parasitic Diseases Therapeutic Products, Services and Solutions
Table 47. Revenue (US$ Million) in Parasitic Diseases Therapeutic Business of Bayer (2024-2024)
Table 48. Bayer Recent Developments
Table 49. F. Hoffmann-La Roche Basic Information List
Table 50. F. Hoffmann-La Roche Description and Business Overview
Table 51. F. Hoffmann-La Roche Parasitic Diseases Therapeutic Products, Services and Solutions
Table 52. Revenue (US$ Million) in Parasitic Diseases Therapeutic Business of F. Hoffmann-La Roche (2024-2024)
Table 53. F. Hoffmann-La Roche Recent Developments
Table 54. GlaxoSmithKline Basic Information List
Table 55. GlaxoSmithKline Description and Business Overview
Table 56. GlaxoSmithKline Parasitic Diseases Therapeutic Products, Services and Solutions
Table 57. Revenue (US$ Million) in Parasitic Diseases Therapeutic Business of GlaxoSmithKline (2024-2024)
Table 58. GlaxoSmithKline Recent Developments
Table 59. Pfizer Basic Information List
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Parasitic Diseases Therapeutic Products, Services and Solutions
Table 62. Revenue (US$ Million) in Parasitic Diseases Therapeutic Business of Pfizer (2024-2024)
Table 63. Pfizer Recent Developments
Table 64. Sanaria Basic Information List
Table 65. Sanaria Description and Business Overview
Table 66. Sanaria Parasitic Diseases Therapeutic Products, Services and Solutions
Table 67. Revenue (US$ Million) in Parasitic Diseases Therapeutic Business of Sanaria (2024-2024)
Table 68. Sanaria Recent Developments
Table 69. North America Parasitic Diseases Therapeutic Market Size by Country (2024-2024) & (US$ Million)
Table 70. North America Parasitic Diseases Therapeutic Market Size by Country (2024-2034) & (US$ Million)
Table 71. Europe Parasitic Diseases Therapeutic Market Size by Country (2024-2024) & (US$ Million)
Table 72. Europe Parasitic Diseases Therapeutic Market Size by Country (2024-2034) & (US$ Million)
Table 73. Asia-Pacific Parasitic Diseases Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 74. Asia-Pacific Parasitic Diseases Therapeutic Market Size by Region (2024-2024) & (US$ Million)
Table 75. Asia-Pacific Parasitic Diseases Therapeutic Market Size by Region (2024-2034) & (US$ Million)
Table 76. Asia-Pacific Parasitic Diseases Therapeutic Market Share by Region (2024-2024)
Table 77. Asia-Pacific Parasitic Diseases Therapeutic Market Share by Region (2024-2034)
Table 78. Latin America Parasitic Diseases Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 79. Latin America Parasitic Diseases Therapeutic Market Size by Country (2024-2024) & (US$ Million)
Table 80. Latin America Parasitic Diseases Therapeutic Market Size by Country (2024-2034) & (US$ Million)
Table 81. Middle East & Africa Parasitic Diseases Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 82. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country (2024-2024) & (US$ Million)
Table 83. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country (2024-2034) & (US$ Million)
Table 84. Parasitic Diseases Therapeutic Market Trends
Table 85. Parasitic Diseases Therapeutic Market Drivers
Table 86. Parasitic Diseases Therapeutic Market Challenges
Table 87. Parasitic Diseases Therapeutic Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parasitic Diseases Therapeutic Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Parasitic Diseases Therapeutic Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Parasitic Diseases Therapeutic Market Share by Regions: 2022 VS 2034
Figure 4. Global Parasitic Diseases Therapeutic Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Parasitic Diseases Therapeutic Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Parasitic Diseases Therapeutic Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Parasitic Diseases Therapeutic Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Parasitic Diseases Therapeutic Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Parasitic Diseases Therapeutic Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Peptides Medicine
Figure 11. Global Peptides Medicine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Insect Repellent
Figure 13. Global Insect Repellent Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Acaricide
Figure 15. Global Acaricide Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Other
Figure 17. Global Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global Parasitic Diseases Therapeutic Market Size Share by Type: 2022 & 2034
Figure 19. North America Parasitic Diseases Therapeutic Revenue Market Share by Type (2024-2034)
Figure 20. Europe Parasitic Diseases Therapeutic Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific Parasitic Diseases Therapeutic Revenue Market Share by Type (2024-2034)
Figure 22. Latin America Parasitic Diseases Therapeutic Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa Parasitic Diseases Therapeutic Revenue Market Share by Type (2024-2034)
Figure 24. Commercial Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Household Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Global Parasitic Diseases Therapeutic Market Size Share by Application: 2022 & 2034
Figure 27. North America Parasitic Diseases Therapeutic Revenue Market Share by Application (2024-2034)
Figure 28. Europe Parasitic Diseases Therapeutic Revenue Market Share by Application (2024-2034)
Figure 29. Asia-Pacific Parasitic Diseases Therapeutic Revenue Market Share by Application (2024-2034)
Figure 30. Latin America Parasitic Diseases Therapeutic Revenue Market Share by Application (2024-2034)
Figure 31. Middle East and Africa Parasitic Diseases Therapeutic Revenue Market Share by Application (2024-2034)
Figure 32. Parasitic Diseases Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 33. Global Top 5 and Top 10 Players Parasitic Diseases Therapeutic Market Share in 2022
Figure 34. North America Parasitic Diseases Therapeutic Market Share by Country (2024-2034)
Figure 35. U.S. Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 36. Canada Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 37. Germany Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 38. France Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 39. U.K. Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 40. Italy Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 41. Russia Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 42. Nordic Countries Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 43. Asia-Pacific Parasitic Diseases Therapeutic Market Share by Region (2024-2034)
Figure 44. China Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 45. Japan Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 46. South Korea Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 47. Southeast Asia Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 48. India Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 49. Australia Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 50. Latin America Parasitic Diseases Therapeutic Market Share by Country (2024-2034)
Figure 51. Mexico Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 52. Brazil Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 53. Middle East & Africa Parasitic Diseases Therapeutic Market Share by Country (2024-2034)
Figure 54. Turkey Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 55. Saudi Arabia Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 56. UAE Parasitic Diseases Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report